Insulin and insulin-like growth factor signalling in neoplasia
- PMID: 19029956
- DOI: 10.1038/nrc2536
Insulin and insulin-like growth factor signalling in neoplasia
Erratum in
- Nat Rev Cancer. 2009 Mar;9(3):224
Abstract
Insulin and insulin-like growth factors (IGFs) are well known as key regulators of energy metabolism and growth. There is now considerable evidence that these hormones and the signal transduction networks they regulate have important roles in neoplasia. Epidermiological, clinical and laboratory research methods are being used to investigate novel cancer prevention and treatment strategies related to insulin and IGF signalling. Pharmacological strategies under study include the use of novel receptor-specific antibodies, receptor kinase inhibitors and AMP-activated protein kinase activators such as metformin. There is evidence that insulin and IGF signalling may also be relevant to dietary and lifestyle factors that influence cancer risk and cancer prognosis. Recent results are encouraging and have justified the expansion of many translational research programmes.
Similar articles
-
The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases.Acta Physiol Hung. 2005;92(2):97-107. doi: 10.1556/APhysiol.92.2005.2.1. Acta Physiol Hung. 2005. PMID: 16268048 Review.
-
Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer.Br J Cancer. 2010 Nov 9;103(10):1479-84. doi: 10.1038/sj.bjc.6605932. Epub 2010 Oct 5. Br J Cancer. 2010. PMID: 20924377 Free PMC article.
-
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors.Biochem Soc Trans. 2001 Aug;29(Pt 4):513-25. doi: 10.1042/bst0290513. Biochem Soc Trans. 2001. PMID: 11498020 Review.
-
[Physiology of the GH-IGF axis].Arq Bras Endocrinol Metabol. 2008 Jul;52(5):717-25. doi: 10.1590/s0004-27302008000500002. Arq Bras Endocrinol Metabol. 2008. PMID: 18797577 Review. Portuguese.
-
The insulin-like growth factor axis in cell cycle progression.Horm Metab Res. 2003 Nov-Dec;35(11-12):740-50. doi: 10.1055/s-2004-814162. Horm Metab Res. 2003. PMID: 14710353 Review.
Cited by
-
Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.J Cancer Res Clin Oncol. 2013 Mar;139(3):491-8. doi: 10.1007/s00432-012-1355-3. Epub 2012 Nov 23. J Cancer Res Clin Oncol. 2013. PMID: 23180020
-
Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs.Front Endocrinol (Lausanne). 2021 Feb 24;12:637209. doi: 10.3389/fendo.2021.637209. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716988 Free PMC article. Review.
-
Metformin: an old but still the best treatment for type 2 diabetes.Diabetol Metab Syndr. 2013 Feb 15;5(1):6. doi: 10.1186/1758-5996-5-6. Diabetol Metab Syndr. 2013. PMID: 23415113 Free PMC article.
-
New insights into pancreatic cancer-induced paraneoplastic diabetes.Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):423-33. doi: 10.1038/nrgastro.2013.49. Epub 2013 Mar 26. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23528347 Free PMC article. Review.
-
Alterations in the proliferative/apoptotic equilibrium in semen of adolescents with varicocele.J Assist Reprod Genet. 2016 Dec;33(12):1657-1664. doi: 10.1007/s10815-016-0808-z. Epub 2016 Sep 14. J Assist Reprod Genet. 2016. PMID: 27629121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous